Increasing tamoxifen dose in breast cancer patients based on CYP2D6 genotypes and endoxifen levels: effect on active metabolite isomers and the antiestrogenic activity score by Barginear M F, Jaremko M, Peter I, Yu C, Kasai Y, Kemeny M, Raptis G, Desnick R J in Clinical pharmacology and therapeutics (2011).

[PMID: 21900890] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.